CPI Card Group (PMTS) experienced a 20% drop after a major secondary sale by Parallel 49 Equity, but the overhang has now cleared. Insider and institutional buying at the secondary price indicates strong confidence in the stock, supported by bullish insider ratings and technical support above $21.90. The company reported 15% revenue growth in Q2 and raised its guidance, projecting 2026 free cash flow between $45–50 million and increasing EPS estimates. Despite these improvements and strategic acquisitions, PMTS trades at a single-digit forward multiple with analyst price targets of $30–$34, supporting a Strong Buy rating.
CPI Card Group's recent developments provide context for financial markets. For readers following Financials-sector stocks, here is Pluang's market snapshot as of Sep 24, 2026 02:21 WIB: Out of 85 priced Financials-sector US stocks, 15 rose and 70 fell. Deutsche Bank AG (DB) traded at USD 35.97 with a 1-day change of -4.23% and 100% buy order activity. Nu Holdings Ltd (NU) was priced at USD 13.57, down 4.13%, with 94% buy orders. Futu Holdings Ltd (FUTU) stood at USD 110.00, down 3.78%, also with 100% buy orders.
NeoVolta reported a weak Q4 with revenue dropping to $13,460 and a loss of $0.24 per share, missing analyst expectations. Despite this, full-year revenue rose 58% to $13.3 million as the company expanded beyond residential markets. The Q4 loss widene...
BlackBerry is expected to report Q3 earnings with an EPS of $0.04 and revenue around $143.55 million, in line with company guidance. The company has a strong track record of beating earnings estimates, driven by growth in its QNX automotive software ...
On September 23, Jaguar Health's stock plunged about 74%, reversing a prior gain, without any confirmed negative news. Alkami Technology's shares fell 19% after ending a strategic review and deciding to remain independent. Other stocks like Cullinan ...
Wheeler REIT (WHLR) surged 190.91% after a 1-for-9 reverse stock split, though no new catalyst was confirmed. Artelo Biosciences (ARTL) rose 74% following a provisional patent application for its obesity drug candidate ART27.13, based on early mouse ...
Costco Wholesale announced $93.9 billion in net sales for its fiscal Q4, up 11.3% from last year, with comparable sales rising 9.4%. The full earnings report on September 24 will reveal membership fees, total revenue, expenses, and profit details. An...
